1. Home
  2. BMRN vs AM Comparison

BMRN vs AM Comparison

Compare BMRN & AM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • AM
  • Stock Information
  • Founded
  • BMRN 1996
  • AM 2013
  • Country
  • BMRN United States
  • AM United States
  • Employees
  • BMRN N/A
  • AM N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • AM Natural Gas Distribution
  • Sector
  • BMRN Health Care
  • AM Utilities
  • Exchange
  • BMRN Nasdaq
  • AM Nasdaq
  • Market Cap
  • BMRN 10.0B
  • AM 8.5B
  • IPO Year
  • BMRN 1999
  • AM 2014
  • Fundamental
  • Price
  • BMRN $52.47
  • AM $18.01
  • Analyst Decision
  • BMRN Buy
  • AM Hold
  • Analyst Count
  • BMRN 18
  • AM 3
  • Target Price
  • BMRN $93.71
  • AM $18.50
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • AM 2.2M
  • Earning Date
  • BMRN 10-28-2025
  • AM 10-29-2025
  • Dividend Yield
  • BMRN N/A
  • AM 5.00%
  • EPS Growth
  • BMRN 154.69
  • AM 18.64
  • EPS
  • BMRN 3.40
  • AM 0.95
  • Revenue
  • BMRN $3,063,608,000.00
  • AM $1,224,620,000.00
  • Revenue This Year
  • BMRN $13.35
  • AM $3.16
  • Revenue Next Year
  • BMRN $9.18
  • AM $3.79
  • P/E Ratio
  • BMRN $15.44
  • AM $18.97
  • Revenue Growth
  • BMRN 18.36
  • AM 7.09
  • 52 Week Low
  • BMRN $51.57
  • AM $14.22
  • 52 Week High
  • BMRN $73.51
  • AM $19.82
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 38.26
  • AM 34.55
  • Support Level
  • BMRN $51.79
  • AM $18.86
  • Resistance Level
  • BMRN $55.39
  • AM $19.46
  • Average True Range (ATR)
  • BMRN 1.36
  • AM 0.35
  • MACD
  • BMRN -0.11
  • AM -0.17
  • Stochastic Oscillator
  • BMRN 19.28
  • AM 2.43

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About AM Antero Midstream Corporation

Antero Midstream Corp is a midstream company that owns, operates, and develops midstream energy assets that service Antero Resources' production and completion activity in the Appalachian Basin located in West Virginia and Ohio. The company has two operating segments; the Gathering and Processing segment includes a network of gathering pipelines and compressor stations that collect and process production from Antero Resources wells in West Virginia and Ohio and the Water Handling segment includes two independent systems that deliver water from sources including the Ohio River, local reservoirs and several regional waterways. It derives a majority of its revenue from the Gathering and Processing segment.

Share on Social Networks: